You are here

  • Home
  • Archive
  • Volume 73, Issue 12
  • Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

Citation Tools

Article menu
XML
Clinical and epidemiological research
Extended report
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Keystone E, Landewé R, van Vollenhoven R, et al
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension
Annals of the Rheumatic Diseases 2014;73:2094-2100.